Rapid Response Partnership Vehicle

Accelerating Innovation For Rapid Health Security Solutions

The Rapid Response Partnership Vehicle (RRPV) helps BARDA speed up the development of medical countermeasures to respond to threats like pandemic flu, emerging infectious diseases, and other biological hazards.

Through a network of technologists, innovators, traditional contractors, large and small business, academia, and nonprofit research institutions that can respond rapidly and effectively to future pandemic or high consequence biological threats.

The consortium unites experts in MedTech, vaccines, and therapeutics to accelerate partnerships and develop medical countermeasures from early research to commercialization. Its goal is to strengthen health security, preparedness, and rapid response to future pandemics and public health emergencies.

Rapidly Producing Countermeasures for Health Security

RRPV is an agile network of technologists, innovators, traditional contractors, large and small businesses, academia, and nonprofit research institutions, that can respond rapidly and effectively to future pandemic or high consequence biological threats. Key focus areas include:

Medical Technology (MedTech)

Tools, equipment, and devices to diagnose and treat patients.

Vaccines/Therapeutics (Vx/Tx)

Biological preparation that is used to stimulate the body’s immune response against pathogens or diseases and medical interventions intended to treat a health issue, infection or disease.

Join RRPV

Why You Should Join?

Direct Government Connections

Flexible Contracting

Rapid Cash Flow Solutions

Insight into Government Needs

Opportunities for Small Businesses

Industry Collaboration Tools

Collaborate with Us

Become a Member